Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.71 USD | -2.07% | -3.72% | -15.27% |
28/05 | NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO | CI |
02/05 | North American Morning Briefing : Stock Futures -3- | DJ |
Sales 2024 * | 66Cr 5.47TCr | Sales 2025 * | 72Cr 6TCr | Capitalization | 175.09Cr 15TCr |
---|---|---|---|---|---|
Net income 2024 * | -7.2Cr -600.57Cr | Net income 2025 * | -4.7Cr -392.04Cr | EV / Sales 2024 * | 3.08 x |
Net Debt 2024 * | 27Cr 2.21TCr | Net Debt 2025 * | 24Cr 1.98TCr | EV / Sales 2025 * | 2.77 x |
P/E ratio 2024 * |
-24.1
x | P/E ratio 2025 * |
-38
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.72% |
Latest transcript on NeoGenomics, Inc.
1 day | -2.07% | ||
1 week | -3.72% | ||
1 month | -6.86% | ||
3 months | -14.15% | ||
6 months | -27.84% | ||
Current year | -15.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 15/22/15 |
Lynn Tetrault
CHM | Chairman | 61 | 12/15/12 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 07/22/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Kelly
BRD | Director/Board Member | 67 | 15/20/15 |
Chris Smith
CEO | Chief Executive Officer | 61 | 15/22/15 |
David Perez
BRD | Director/Board Member | 63 | 03/22/03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.43% | 14 M€ | -5.07% | ||
0.97% | 11 M€ | -6.03% | - | |
0.29% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 13.71 | -2.07% | 679,145 |
30/24/30 | 14 | +1.23% | 409,958 |
29/24/29 | 13.83 | -2.12% | 346,165 |
28/24/28 | 14.13 | -0.77% | 490,869 |
Delayed Quote Nasdaq, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.27% | 175.09Cr | |
-24.16% | 776.06Cr | |
+68.65% | 433.23Cr | |
-2.98% | 264.08Cr | |
+2.72% | 263.49Cr | |
-46.17% | 216.15Cr | |
-22.12% | 146.25Cr | |
+13.62% | 117.04Cr | |
-43.81% | 114.45Cr | |
+20.41% | 100Cr |
- Stock Market
- Equities
- NEO Stock